By Tova Cohen RAANANA, Israel (Reuters) Israel’s UroGen Pharma plans to begin a mid-stage trial of its treatment for Bladder Cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer UroGen’s shares have more than tripled in the past year. In May, it […]

The post Israel’s UroGen to Start Mid-Stage Bladder Cancer Trial appeared first on OMG News Today.